This program is sponsored by Santen.
Case Studies
This program is sponsored by Santen.
This program is sponsored by Eyevance Pharmaceuticals, a Santen company
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
4DMT releases positive interim 1.5- to 3.5-year data from phase 1/2 PRISM trial
2
Opus Genetics has Type B RMAT meeting with FDA for its gene therapy candidate, OPGx-LCA5
3
Beyond The Walls: The “how and why” behind what drives today’s ophthalmologists
4
Q&A: Karolinne M. Rocha discusses the IOL and patient tolerance of residual astigmatism
5
.png "Optometry Times"){kind=logo}
